Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 2, 2023 (Week 48)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 14,485 32,999 1,369,659 1,531,348
New England 201 1,650 37,842 48,793
Connecticut - 430 1,155 11,513
Maine 53 75 2,747 2,915
Massachusetts - 687 25,664 26,307
New Hampshire 50 82 2,563 2,629
Rhode Island 78 694 4,510 4,238
Vermont 20 37 1,203 1,191
Middle Atlantic 2,562 4,185 180,931 178,156
New Jersey - 789 29,933 30,884
New York (excluding New York City) 943 1,032 38,836 37,016
New York City 754 1,497 61,614 59,465
Pennsylvania 865 1,231 50,548 50,791
East North Central 1,548 4,577 180,665 211,634
Illinois 82 1,811 48,572 65,813
Indiana 225 879 29,102 31,312
Michigan 250 881 30,681 39,858
Ohio 627 1,211 50,105 50,722
Wisconsin 364 562 22,205 23,929
West North Central 926 2,137 86,945 94,402
Iowa 127 333 12,506 13,718
Kansas 65 335 9,923 13,052
Minnesota 190 497 19,862 20,605
Missouri 419 746 29,394 29,726
Nebraska - 246 7,636 8,970
North Dakota 69 91 3,113 3,453
South Dakota 56 123 4,511 4,878
South Atlantic 3,259 7,719 302,559 341,702
Delaware - 227 5,144 4,772
District of Columbia 96 199 5,975 7,594
Florida 1,363 2,784 103,649 98,208
Georgia 703 1,550 60,439 67,639
Maryland U NC U 28,489
North Carolina - 1,446 55,362 59,935
South Carolina 521 774 30,496 33,104
Virginia 549 976 37,485 37,795
West Virginia 27 115 4,009 4,166
East South Central 1,065 2,452 83,898 102,528
Alabama 626 972 31,358 28,829
Kentucky 318 546 15,586 16,828
Mississippi 121 487 16,704 21,566
Tennessee - 1,094 20,250 35,305
West South Central 834 4,853 186,815 214,704
Arkansas 181 435 15,891 16,719
Louisiana 344 876 33,035 33,771
Oklahoma 59 472 14,218 18,965
Texas 250 3,191 123,671 145,249
Mountain 1,001 2,568 100,816 109,211
Arizona 494 880 37,241 38,032
Colorado 4 844 23,046 24,310
Idaho 40 144 5,264 5,530
Montana 40 92 3,079 3,837
Nevada 222 331 10,816 15,075
New Mexico 14 256 9,747 10,411
Utah 187 255 10,233 10,339
Wyoming - 50 1,390 1,677
Pacific 3,089 5,049 209,188 230,218
Alaska 76 121 3,815 4,951
California 2,154 4,112 173,102 178,994
Hawaii - 132 - 5,109
Oregon 288 382 14,053 14,492
Washington 571 565 18,218 26,672
U.S. Territories - 102 1,138 4,316
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 102 1,138 4,316
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 5 47 127
Total 14,485 33,085 1,370,844 1,535,791
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.